BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
14 results:

  • 1. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
    Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
    Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Implementation of an organized colorectal cancer screening program through quantitative fecal immunochemical test followed by colonoscopy in an urban low-income community: Guidance and strategies.
    Ribeiro U; Safatle-Ribeiro AV; Sorbello M; Kishi PHR; Cohend DD; Mattar R; Castilho VLP; Goncalves EMDN; Kawaguti F; Marques CFS; Alves VAF; Nahas SC; Eluf-Neto J
    Clinics (Sao Paulo); 2023; 78():100278. PubMed ID: 37639912
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis.
    Khanmohammadi S; Behnoush AH; Akhlaghpoor S
    PLoS One; 2023; 18(8):e0289975. PubMed ID: 37585405
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
    He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
    Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal treatment Strategy of Chemotherapeutic Intervention in Patients with colorectal Liver Metastases.
    Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
    Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    van 't Erve I; Wesdorp NJ; Medina JE; Ferreira L; Leal A; Huiskens J; Bolhuis K; van Waesberghe JTM; Swijnenburg RJ; van den Broek D; Velculescu VE; Kazemier G; Punt CJA; Meijer GA; Fijneman RJA
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34820593
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
    Ghani MA; Fereydooni A; Chen E; Letzen B; Laage-Gaupp F; Nezami N; Deng Y; Gan G; Thakur V; Lin M; Papademetris X; Schernthaner RE; Huber S; Chapiro J; Hong K; Georgiades C
    Eur Radiol; 2021 Dec; 31(12):8858-8867. PubMed ID: 34061209
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Can we optimize CEA as a response marker in rectal cancer?
    Gago T; Caldeira P; Cunha AC; Campelo P; Guerreiro H
    Rev Esp Enferm Dig; 2021 Jun; 113(6):423-428. PubMed ID: 33228364
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
    Wu X; Lin H; Li S
    BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases.
    Simoneau E; Aljiffry M; Salman A; Abualhassan N; Cabrera T; Valenti D; El Baage A; Jamal M; Kavan P; Al-Abbad S; Chaudhury P; Hassanain M; Metrakos P
    HPB (Oxford); 2012 Jul; 14(7):461-8. PubMed ID: 22672548
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of endoscopic mucosal resection for laterally spreading rectal tumors.
    Tamura S; Nakajo K; Yokoyama Y; Ohkawauchi K; Yamada T; Higashidani Y; Miyamoto T; Ueta H; Onishi S
    Endoscopy; 2004 Apr; 36(4):306-12. PubMed ID: 15057679
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Conservative treatment for carcinoma of the anus--a report of 35 patients.
    Serkies K; Bednaruk-Mlynski E; Dziadziuszko R; Jassem J
    Neoplasma; 2003; 50(2):152-8. PubMed ID: 12740652
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group.
    Bosset JF; Horiot JC; Hamers HP; Cionini L; Bartelink H; Caspers R; Untereiner M; Ciambelloti E; Pierart M; Van Glabbeke M
    Radiother Oncol; 2001 Oct; 61(1):7-13. PubMed ID: 11578723
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A comparative study with two administration schedules of leucovorin and 5-fluorouracil in advanced colorectal cancer.
    Tsavaris N; Foutzilas G; Markantonakis P; Mylonakis N; Bacoyannis C; Zisiadis A; Basdanis G; Karvounis N; Sobolos K; Kosmidis P
    J Chemother; 1995 Feb; 7(1):71-7. PubMed ID: 7629565
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.